Rigel Pharmaceuticals Other Long Term Assets (Quarterly) Insights

Rigel Pharmaceuticals, Inc. (RIGL)

36.96 +0.62 (+1.71%) USD | NASDAQ | Jan 21, 10:19

View Other Long Term Assets (Quarterly) for RIGL.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Assets (Quarterly) Benchmarks

Start Trial

Nektar Therapeutics	Upgrade
Ironwood Pharmaceuticals, Inc.	Upgrade
Catalyst Pharmaceuticals, Inc.	--
Perspective Therapeutics, Inc.	Upgrade
Vertex Pharmaceuticals, Inc.	Upgrade